Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines
Novavax Inc. on Tuesday tweaked its full-year sales outlook to the low end of its…
Read MoreNovavax Inc. on Tuesday tweaked its full-year sales outlook to the low end of its…
Read MoreNovavax Inc. NVAX, -1.88% said Tuesday a late-stage trial of its vaccine targeting the COVID…
Read MoreNovavax Inc. NVAX, -10.14% said Tuesday that one million doses of its protein-based COVID vaccine…
Read MoreShares of Novavax Inc. NVAX, -11.25% slumped 7.1% in morning trading Thursday, to extend their…
Read MoreStocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said…
Read MoreFirst lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read MoreThe Food and Drug Administration authorized Novavax Inc.’s NVAX, -2.58% COVID-19 vaccine for use in…
Read MoreNovavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial…
Read MoreChinese authorities have closed Tibet’s Potala Palace after a small outbreak of COVID cases in…
Read MoreChinese authorities have closed Tibet’s Potala Palace after a small outbreak of COVID cases in…
Read More